Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil Open-Label Extension in PD Dementia
NCT01327859Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2003
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in Parkinson's disease dementia (PDD), sponsored by Eisai Co., Ltd.. Started Mar 2003; status: completed.
02
Drugs
donepezil
03
Conditions
Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT01327859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327859.